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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYAlthough endothelial cells have been shown to affect mouse pancreatic development, their precise function in human development
remains unclear. Using a coculture system containing human embryonic stem cell (hESC)-derived progenitors and endothelial cells,
we found that endothelial cells play a stage-dependent role in pancreatic development, in which they maintain pancreatic progenitor
(PP) self-renewal and impair further differentiation into hormone-expressing cells. The mechanistic studies suggest that the endothelial
cells act through the secretion of EGFL7. Consistently, endothelial overexpression of EGFL7 in vivo using a transgenic mouse model
resulted in an increase of PP proliferation rate and a decrease of differentiation toward endocrine cells. These studies not only identified
the role of EGFL7 as the molecular handle involved in the crosstalk between endothelium and pancreatic epithelium, but also provide a
paradigm for using hESC stepwise differentiation to dissect the stage-dependent roles of signals controlling organogenesis.INTRODUCTION
During embryonic development, cell fate is determined by
both intrinsic programs and external cell niche. The animal
studies suggested that endothelial cell niche provides both
supportive and inductive roles throughout pancreas devel-
opment (Eberhard et al., 2010). Early studies showed that
signals from endothelial cells are essential for the induction
of pancreatic organogenesis (Lammert et al., 2001). Endo-
thelial cells specifically promote early dorsal pancreas
development by inducing Ptf1a+ pancreatic progenitors
(PPs) by activating FGF10 signaling (Yoshitomi and Zaret,
2004; Jacquemin et al., 2006). Interestingly, some groups
recently reported that the endothelial cell niche could
restrain epithelium branching and endocrine develop-
ment. One group shows that blood vessel ablation results
in increased pancreatic organ size (Sand et al., 2011).
Another group showed that elimination of endothelial
cells increases the size of pancreatic buds (Magenheim
et al., 2011). Similarly, another group showed that overex-
pressing vascular endothelial growth factor A increases
embryonic endothelial cell populations and perturbs pan-
creatic endocrine differentiation (Cai et al., 2012). How-
ever, a complete understanding of the role of endothelial
cells in human pancreatic development is still missing.
Human embryonic stem cells (hESCs) provide an in vitro
platform to study human development. To better under-
stand the signaling from the endothelial cell niche in
pancreatic differentiation, we have developed a cocultureStem Cellsystem of endothelial cells with hESC-derived progenitors
under serum-free, chemical-defined conditions. By using
the coculture system, we found that endothelial cells main-
tain PP self-renewal and impair further differentiation into
hormone-expressing cells by secreting EGFL7.RESULTS AND DISCUSSION
Endothelial Cells Promote the Proliferation of PDX1+
Cells in the Chemically Defined Environment
To systematically probe the role of an endothelial cell niche
in human pancreatic development, we set up a coculture
system using endothelial cells and hESCs-derived progeni-
tors. The coculture system is established in a chemically
defined culture condition tomimic the serum-free environ-
ment during embryonic development. The endothelial
cells used in this study were AKT-HUVECs (AKT-activated
human umbilical vein endothelial cells) (Kobayashi et al.,
2010) or MPECs (mouse pancreas islet endothelial cells).
BJ cells, which are human skin fibroblasts, were used as a
control for cell-type specificity. To explore the stage-depen-
dent effect of endothelial cells, HUES8 cells were differenti-
ated into three different stages: definitive endoderm (DE),
foregut endoderm (FE), or PP populations using a previ-
ously established strategy (Chen et al., 2009). The hESC-
derived populations were cultured together with MPECs
or AKT-HUVECs at different ratios and examined for their
capacities to self-renew or differentiate (Figure 1A). TheReports j Vol. 4 j 181–189 j February 10, 2015 j ª2015 The Authors 181
Figure 1. The Role of Endothelial Cells in Human Pancreatic Differentiation
(A) Scheme of coculture between endothelial cells and hESC-derived progenitors.
(B) Cell number per mm2 after HUES8-derived FE population were cocultured with BJ cells, MPECs, or AKT-HUVECs at indicated ratios
(n = 3).
(C) Cell number per mm2 (n = 3) and representative images after HUES8-derived PP population were cocultured with BJ cells, MPECs or
AKT-HUVECs. The left scale bar represents 50 mm. The right scale bar represents 10 mm.
Data were presented as mean ± SD.self-renewal ability was determined by immunostaining
with antibodies against a proliferation marker (Ki67) and
stage-dependent self-renewal markers, including SOX17
for DE,HNF4a for FE, and PDX1 for PPs. The differentiation
ability was determined by immunostaining with anti-
bodies against differentiation markers, including HNF4a
for DE, PDX1 for FE, and insulin/glucagon/somatostatin
for PPs.
In the coculture condition of MPECs or AKT-HUVECs
with the hESCs-derived DE population, neither the num-
ber of SOX17+/Ki67+ cells nor the number of HNF4a+ cells
changed significantly (Figure S1A available online), sug-
gesting that endothelial cells do not affect either self-
renewal or differentiation of DE. In the coculture condition182 Stem Cell Reports j Vol. 4 j 181–189 j February 10, 2015 j ª2015 The Awith the hESC-derived FE population, the number of
PDX1+ cells was significantly increased in the presence of
MPECs and AKT-HUVECs, but not BJ cells (Figure 1B). In
addition, when the hESCs-derived PP population was
cultured with MPECs and AKT-HUVECs, the number of
PDX1+ cells was significantly elevated as compared with
BJ cells (Figure 1C). The results suggest that endothelial
cells, not fibroblasts, promote the generation of PDX1+
cells at the FE and PP stages.
Next, we asked whether the generation of PDX1+ cells is
due to cell proliferation, by examining the proliferation
marker Ki67. In cocultures using the HUES8-derived PP
population, the number of PDX1+/Ki67+ cells is signifi-
cantly higher in the presence of MEPCs and AKT-HUVECsuthors
than control conditions (Figure 1C). To further validate
that endothelial cells promote PP proliferation, we gener-
ated a transgenic Pdx1-EGFP HUES8 cell line, which con-
tains the mouse Pdx1 promoter driving expression of
EGFP. The Pdx1-EGFP HUES8 cell line was validated by
flow cytometry. After 14 days of differentiation, about
45% of cells were EGFP+, most of which were positively
stained by PDX1 antibody (Figure S1B). Pdx1-EGFP+ cells
were sorted and cocultured with MPECs, AKT-HUVECs, or
BJ cells (Figure S1C). The result confirmed that endothelial
cells can support the isolated PDX1+ cell proliferation.
Interestingly, when we cocultured the PP population with
endothelial cells, we observed that the differentiation of
PPs to hormone-expressing cells was impaired (Figures
S1D and S1E). In addition, endothelial cells show similar
capacities to increase the number of PDX1+ cells and
PDX1+/Ki67+ cells when cocultured with H1-derived PP
population (Figure S1F), suggesting that the effect of
endothelial cells is not hESCs line dependent. These data
together suggest that endothelial cells provide a niche
to maintain proliferation and impair differentiation of
PDX1+ cells toward hormone-expressing cells.
PDX1+ Cells after Coculture with Endothelial Cells
Retain PP Signature Gene Expression
To determine the cellular identity of PDX1+ cells after
coculture with endothelial cells, cells were stained with
other antibodies against progenitor markers. Immunocyto-
chemistry suggested that most PDX1+ cells grew in the
presence of endothelial cells expressed PP markers, HNF6,
SOX9, and FOXA2 and endocrine marker, NKX6.1 (Fig-
ure 2A). The quantified results suggest that the number of
PDX1+/NKX6.1+ cells, PDX1+/FOXA2+ cells, PDX1+/
HNF6+ cells, and PDX1+/SOX9+ cells were higher in the
endothelial cell coculture conditions than in control cells
(Figure 2B).We further tested the mRNA expression of PP
markers (FOXA2, HNF6, and SOX9) and endocrine progen-
itor markers (NKX6.1, NKX2.2, and NGN3) in the purified
Pdx1-GFP+ cells. Quantitative RT-PCR (qRT-PCR) suggested
that the expression of PP markers (FOXA2, HNF6, and
SOX9; Figures S2B, S2D, and S2E) and endocrine progenitor
markers (NKX6.1; Figure S2C) in sorted Pdx1-EGFP+ cells
was elevated in MPEC coculture condition, but the expres-
sion of endocrine progenitor markers (NGN3 and NKX2.2;
Figures S2F and S2G) did not significantly differ between BJ
and MPEC coculture conditions (Figure S2F, at day 4, p =
0.1274 for none versus MPECs; p = 0.8968 for BJ versus
MPECs). It suggested that PDX1+ cells after coculture with
endothelial cells bias to endocrine fate, but have not ex-
pressed the endocrine progenitor markers yet. Next, we
investigated whether the increased PP population under
coculture conditions was due to cell proliferation by
measuring the number of PDX1+/Ki67 cells that are alsoStem Cellpositive for other PPmarkers (Figure 2C). When cocultured
with MPECs and AKT-HUVECs, the number of prolif-
erating PPs increased about 5-fold and 6- to 8-fold,
respectively, compared with noncoculture conditions.
Sometimes, the number of the proliferating PPs in the pres-
ence of BJ cells is lower than noncoculture condition. This
might due to the high cell density in coculture condition,
which might affect PP proliferation.
Transcriptome profiling provides a way to systematically
compare gene expression in different cell populations. PPs
before or after coculturewith endothelial cells were profiled
by RNA-seq. To purify the PDX1+ PPs, EGFP+ cells were
sorted from the Pdx1-EGFP HUES8 cell-derived cells before
or after coculture with MPECs or AKT-HUVECs. The global
gene expression of PPs before and after coculture with
endothelial cells showed very high similarity (R2 = 0.9611
in the presence of AKT-HUVECs; Figure 2D left; and R2 =
0.9378 in the presence of MPECs, Figure S2A). In addition,
the global gene expression pattern of PPs expanded in the
presence of either AKT-HUVECs or BJ cells showed high
similarity (R2 = 0.9692; Figure 2D, right). The data confirm
that PPs maintain cellular identity after expansion by
endothelial cells.
Endothelial Cells Maintain Human PP Self-Renewal
by Secreting EGFL7
In the coculture system, endothelial cells might function
through a secreted factor(s) or by direct cell-cell contact.
To test these possibilities, HUES8 cell-derived PP popula-
tions were treated with conditioned medium (Hebrok
et al., 2000) collected from MPECs (MPEC-CM) or from
AKT-HUVECs (AKT-HUVEC-CM). CM retained similar,
but slightly lower, activity compared with intact cells for
promoting PP self-renewal (Figure 3A). These data suggest
that endothelial cells function, at least in part, through a
secreted factor(s). We further analyzed the gene expression
profiles of AKT-HUVECs, MPECs, and BJ cells to identify
candidate secreted factors (Figures 3B and S3A). Genes en-
coding secreted proteins, whose expression in endothelial
cells is at least 30-fold higher than in the BJ cells, were
selected for further analysis. Among the genes encoding
secreted molecules (Table S1), we tested the abilities of
recombinant proteins ANGPT2, EGFL7, CCL13, IL24,
PLAU, DHH, and PDGFB to expand human PPs (Figure 3C).
Only EGFL7 was able to promote PP proliferation (Figures
3C–3E). To determine whether EGFL7 was required for
the endothelial cell effect, we used shRNA to knockdown
EGFL7 expression in AKT-HUVECs. EGFL7 mRNA expres-
sion level was decreased by about 63.5% in AKT-HUVECs
infected with EGFL7 shRNA lentivirus as compared with a
scrambled control lentivirus (Figure S3B).When cocultured
with EGFL7-shRNA-treated AKT-HUVECs, hESC-derived
PPs showed significantly lower proliferation activity asReports j Vol. 4 j 181–189 j February 10, 2015 j ª2015 The Authors 183
Figure 2. The Cellular Identity of PDX1+
PPs Expanded in Endothelial Cell Niche
(A) Representative figures of PDX1+ cells
costained with another PP marker, FOXA2,
HNF6, or SOX9 and endocrine progenitor
marker, NKX6.1 under coculture conditions.
Scale bar represents 50 mm.
(B) Relative cell number of PDX1+ cells
costained with another progenitor marker
(n = 3). The relative cell number normalized
to control (none) as one.
(C) Quantified results of the relative cell
numbers of PDX1+/Ki67+ cells costained
with another progenitor marker (n = 3).
(D) Transcriptome analysis by RNA-seq of
Pdx1-EGFP+ cells before and after cocultured
with endothelial cells. The scatter plot
showed mRNA expression level in sorted
Pdx1-EGFP+ cells before coculture versus
after coculture with AKT-HUVECs (left) or
after coculture with BJ cells versus after
coculture with AKT-HUVECs (right).
Data were presented as mean ± SD.compared with those cocultured with untreated (p =
0.0324) and scrambled-shRNA-treated AKT-HUVECs (p =
0.0387; Figures 3F and 3G). These results indicate that
EGFL7 is both sufficient and necessary for endothelial cells
to maintain PP self-renewal.
Since EGFL7 has been shown to modulate the NOTCH
pathway (Nichol et al., 2010), we tested whether the
NOTCHpathway is involved in endothelial cell-dependent
PP expansion. HUES8-derived PP populations were treated
with five different NOTCH inhibitors, includingDAPT, XX,184 Stem Cell Reports j Vol. 4 j 181–189 j February 10, 2015 j ª2015 The Acompound E, III-31-C, and Sulindac sulfide. None of them
mimics EGFL7 effect to promote PP proliferation (Fig-
ure S3C). In addition, qRT-PCR analysis showed that
EGFL7 treatment did not alter the expression of NOTCH
target genes, such as Hes-1 and Hey-1, in Pdx1-GFP+ cells
(Figure S3D).
Recent studies suggested that EGFL7 might also activate
EGF receptor pathway (Luo et al., 2014; Wu et al.,
2009). Several experiments were performed to determine
whether EGF receptor is a downstream signal of EGFL7.uthors
Figure 3. Endothelial Cells Promote PP
Proliferation by Secretion of EGFL7
(A) Cell number per mm2 4 days after
HUES8-derived PPs were cocultured with
endothelial cells or treated with CM (n = 3).
(B) Transcriptome analysis of gene expres-
sion in BJ cells and AKT-HUVECs by RNA-
seq. The blue line indicates the cutoff line
of a 30-fold increase in gene expression in
AKT-HUVECs as compared with BJ cells. The
red dot indicates EGFL7.
(C) Number of PDX1+ cells per mm2 4 days
after hESC-derived PPs were treated with
different recombinant proteins (300 ng/ml)
(n = 3).
(D) PDX1+ (left) or PDX1+/Ki67+ cell number
per mm2 (right) 4 days after HUES8-derived
PPs were treated with CM or 300 ng/ml
EGFL7 (n = 3).
(E) Representative images of (D).
(F) PDX1+/Ki67+ cell number per mm2 4 days
after HUES8-derived PPs were cocultured
with AKT-HUVECs carrying shRNA targeting
EGFL7 (shRNA-EGFL7) or AKT-HUVECs car-
rying scrambled control shRNA (scrambled)
(n = 3).
(G) Representative images of (F).
Data were presented as mean ± SD.Immunocytochemistry suggests that the EGF receptor is
expressed in hESC-derived PDX1+ PPs (Figure S3E). In addi-
tion, microscale thermophoresis binding assay suggested
that EGFL7 directly binds to the EGF receptor in vitro
(Kd = 384 ± 76.5 nM; Figure S3F). Furthermore, we found
that addition of an epidermal growth factor receptor inhib-
itor (EGFRi) blocks the effect of endothelial cells and EGFL7
to expand PDX1+ PPs (Figure S3G). Finally, we found
that mRNA expression level for EGF is much lower in
AKT-HUVECs (0.09 ± 0.02) and MPECs (0.09 ± 0.02) than
BJ fibroblasts (0.6 ± 0.1), as determined by RNaseq (Fig-Stem Cellure S3H). Since endothelial cells, but not BJ fibroblasts, pro-
mote PPs self-renewal, this suggests that endothelial cells
do not promote PP proliferation by secreting EGF. Together,
these results indicate that endothelial cells promote PP self-
renewal through the secretion of EGFL7 and through acti-
vation of the EGF receptor signaling pathway.
To determine whether EGFL7 treatment is capable of
promoting PP proliferation in long-term cultures, we
tested the expansion and differentiation capacity of
PDX1+ PPs to the endocrine lineage following the pulsed
expansion with recombinant EGFL7. HUES8-derived PPReports j Vol. 4 j 181–189 j February 10, 2015 j ª2015 The Authors 185
populations were treated with EGFL7 for different periods
of time. One set of samples was fixed and stained with
PDX1 and Ki67 antibodies to determine cell proliferation
rates. The other set of samples were further differentiated
in the absence of EGFL7 for additional 7 days and stained
with antibodies against endocrine markers to determine
the differentiation potential. The percentage of PDX1+/
Ki67+ cells increased during the first week of EGFL7 treat-
ment (Figure S3I). After 1 week, the percentage of PDX1+/
Ki67+ cells started decreasing in all conditions no matter
whether EGFL7 was present. However, the percentages of
PDX1+/Ki67+ cells treated with EGFL7 are higher than
those of under control condition at all time points (Fig-
ure S3I). Consistent with the increase in cell proliferation,
the percentage of insulin+, C-peptide+, and somatostatin+
cells increased in PPs cultured under EGFL7 treatment
and peaked at 1 week. The percentage of hormone-express-
ing cells under EGFL7-treated conditions is higher than
that under control condition at all time points (Figures
S3H–S3L). Together, these results suggest that one week
of EGFL7 treatment can expand PDX1+ PPs in vitro, result-
ing in significantly increased differentiation efficiency to-
ward the endocrine cell lineages.
Endothelial Overexpression of Egfl7 In Vivo Increases
Proliferation of PPs
To determine the effect of EGFL7 on the PP cell population
in vivo, we analyzed pancreatic development in a trans-
genic mouse model, Tie2:Egfl7. In this strain, the Egfl7
transgene is under the control of the endothelial-specific
Tie2 promoter, resulting in a 2- to 3-fold overexpression
of EGFL7 (Nichol et al., 2010). All animal protocols were
approved by the Institutional Animal Care and Use Com-
mitttee at Weill Cornell Medical College. Whole-mount
immunofluorescent staining was performed on E9.5 and
E10.5 embryos from C57BL/6 WT mice and Tie2:Egfl7
transgenic mice (TG) (Figures 4A and 4D). A CD31-positive
capillary plexus surrounds the developing pancreatic bud
in vivo, demonstrating the proximity of endothelial cells
and implicating them as a potential source of EGFL7 to
signal to the PDX1+ PP population (Figure S4A). Quantifica-
tion of the vascular coverage at E10.5 demonstrated no sig-
nificant difference in blood vessel density surrounding the
developing pancreatic bud between WT and TG mice (Fig-
ure S4B, p = 0.299).
At E9.5 and E10.5, the pancreatic buds of TGmice appear
larger with less defined edges as compared with WT mice
(Figures 4B–4F). To determine whether the larger pancre-
atic buds in the TG embryos resulted from increased prolif-
eration of PDX1+ cells, we performed EdU injections of
pregnant E10.5 WT and TG mice (Figures 4G and 4H). We
analyzed the percentage of EdU+ PP (PDX1+) cells in sec-
tions of pancreatic buds (Figure 4I). The percentage of186 Stem Cell Reports j Vol. 4 j 181–189 j February 10, 2015 j ª2015 The Aproliferating PPs (EdU+/PDX1+) in TG mice is significantly
higher thanWTmice (*p < 0.05; Figure 4I). In addition, the
PDX1+ area in TGmice is significantly increased compared
with WT mice (*p = 0.031 in Figure S4C and *p = 0.032 in
Figure S4D). The number of PDX1+ cells in TG mice show
the same trend toward increase as the PDX1+ area,
although it does not reach significance (p = 0.1144 in Fig-
ure S4E, p = 0.065 in Figure S4F). The increase of the num-
ber of PDX1+ cells in TGmice is more pronounced at E15.5
(Figures S4G and S4H, ***p < 0.001). Together, these data
suggest that PP proliferation was stimulated by endothe-
lial-specific overexpression of EGFL7 in vivo.
In addition,WTE11.5 pancreatic budswere isolated from
surroundingmesenchyme and cultured in vitro in the pres-
ence or absence of recombinant mouse EGFL7 for 2 days.
The explants were pulsed for 4 hr with BrdU prior to fixa-
tion. The percentage of proliferating PPs (BrdU+/PDX1+
cells) out of the total number of PPs (PDX1+ cells) was
significantly increased in the presence of mouse recombi-
nant EGFL7 (**p < 0.01, Figures 4J and 4K).
To determine the effect of EGFL7 in vivo on differen-
tiation into hormonal-expressing cells, we analyzed the
percentage of insulin+ cells and PDX1+ cells in E15.5
pancreatic buds (Figure 4L). The percentage of insulin+ cells
over PDX1+ cells in E15.5 pancreatic buds is significantly
decreased in TG mice (*p < 0.05, Figure 4M). Consistently,
the ratio of insulin+ area over E-cadherin+ area in E15.5 TG
pancreatic buds shows a trend toward decrease compared
with WT controls (Figures S4G and S4I, p = 0.396),
although it does not reach significance. We also examined
the total number of PDX1+ cells and the percentages of
PDX1+/NKX6.1+ cells, PDX1+/SOX9+ cells and PDX1+/
NKX6.1+/SOX9+ cells in total PDX1+ cells at E15.5. Consis-
tent with our results for E9.5 and E10.5 embryos, the total
number of PDX1+ cells in E15.5 TG pancreatic buds is
significantly higher than that of WT controls (Figure S4H,
***p < 0.001). The ratios of PDX1+/NKX6.1+ cells (p =
0.385), PDX1+/SOX9+ cells (p = 0.200), and PDX1+/
NKX6.1+/SOX9+ cells (p = 0.495) in PDX1+ cells do not
differ significantly between TG and WT pancreatic buds
(Figures S4J and S4K). Importantly, less than 6% of total
PDX1+ cells coexpress NGN3 in both WT and TG pancre-
atic buds (Figures S4L and S4M, p = 0.053), suggesting
that these PPs have not yet fully committed to endocrine
progenitors. Together, these data suggest that EGFL7 sup-
presses PP differentiation into pancreatic endocrine cells,
which is consistent with our results using hESC-derived
cells (Figures S1D and S1E).
To determine the effect of EGFL7 overexpression in adult
beta cell function, we performed a glucose-stimulated insu-
lin secretion (GSIS) test and a glucose tolerance test (GTT)
in 8-week-old male TG and WT mice. Strikingly, all four
TG mice showed significantly less insulin secretion atuthors
Figure 4. EGFL7 Increases Proliferation of PPs in Both TG and Explant Cultures
(A and D) Representative collapsed z stack confocal image of (A) E9.5 and (D) E10.5 mouse pancreatic buds costained for DAPI, PP marker
PDX1, and endothelial cell marker, CD31.
(B, C, E, and F) Representative collapsed z stack confocal images of E9.5 and E10.5 pancreatic buds from WT and TG mice stained for PDX1.
(G and H) Representative Images of E10.5 mouse pancreatic bud sections from (G) WT and (H) TG mice, costained for PP marker, PDX1, and
proliferation marker, EdU.
(I) Quantification of the percentage of EdU+/PDX1+ cells of E10.5 WT and TG mice (n = 3).
(J) Representative images of E11.5 WT pancreatic bud explants treated with or without 1 mg/ml recombinant mouse EGFL7 and costained
for DAPI, Pdx1, and BrdU.
(K) Quantification of the percentage of BrdU+/Pdx1+ cells of E11.5 WT pancreatic buds treated with or without recombinant EGFL7 (n = 6).
(L) Representative images of E15.5 dorsal and ventral pancreatic buds from WT and TG mice, costained for PP marker, PDX1, and insulin.
(M) Quantification of the ratio of insulin+ cells over PDX1+ cells of E15.5 pancreatic buds from WT and TG mice (n = 5).
(N) Glucose-stimulated insulin secretion (GSIS) test of WT control (n = 3) and TG (n = 4) mice.
(O) GTT of WT (n = 2) and TG (n = 4) mice.
Data were presented as mean ± SEM.both fasting and after glucose stimulation compared with
WT controls (fasting, *p = 0.048; after glucose stimulation,
*p = 0.027, Figure 4N). Furthermore, the TG mice showed
consistently impaired glucose tolerance (Figure 4O). The
data suggest that adult TG mice have less functional beta
cells than WT control mice.Stem CellStepwise differentiation of hESCs provides a useful plat-
formto studyhumandevelopment.Using a stepwisepancre-
atic differentiation system,we found that an endothelial cell
niche plays a stage-dependent role in human pancreatic
development, promoting PP self-renewal and impairing
differentiation from PPs toward hormone-expressing cells.Reports j Vol. 4 j 181–189 j February 10, 2015 j ª2015 The Authors 187
Our finding could explain the results from previous animal
studies: removing endothelial cells before thePP stage blocks
pancreatic development (Lammert et al., 2001),while forced
hypervascularization at the PP stage negatively impacts the
later endocrine differentiation (Cai et al., 2012; Magenheim
et al., 2011; Sand et al., 2011). During pancreatic develop-
ment, the endothelium pattern changes dramatically over
time; this might affect the local concentration of paracrine
factors, such as EGFL7, which will contribute to the cell
fate decision. On the other hand, a recent study proposed
that the endothelial cell niche could stimulate PPs to differ-
entiate into insulin-secreting cells (Jaramillo and Banerjee,
2012). In contrast to our coculture conditions, in which
MPECs and AKT-HUVECs survive well after 4 days of cocul-
ture (Figure S4N), the rat microvascular endothelial cells in
that study do not survive well in differentiation conditions
and could not be detected after 6 days in culture (Jaramillo
and Banerjee, 2012). Although increased insulin expression
was detected in the cocultures, we can speculate that the
ratmicrovascular endothelial cellsmight provide a transient
amplifying signal to expand PPs. If the endothelial cells start
to die, the block on differentiation of PPs would be relieved.
To test this hypothesis, we cultured hESC-derived PPs in
endothelial cell CM for 4 days. The medium was then
removed to induce spontaneous differentiation. Consistent
with our hypothesis, the hESC-derived cells treated with
CM show better differentiation toward insulin-expressing
cells (Figure S4O).
EGFL7 is a secreted protein that acts as a chemoattractant
for endothelial cells, binds to the extracellular matrix, and
promotes endothelial cell adhesion (Schmidt et al., 2007).
Here, we identified the role of EGFL7 as the molecular
handle involved in the crosstalk between endothelium
and pancreatic epithelium, which play as a gatekeeper to
maintain PP self-renewal. In this context, it is interesting
to note that the developmental stage of pancreatic bud for-
mation (E9.0–E11.5) coincides with the peak in EGFL7
expression in the embryonic vasculature (Fitch et al.,
2004). Our data also suggested that EGFL7 might function
through EGF signaling pathway. Consistently, it has been
shown that activation of EGF signaling facilitates the
PDX1+ cells expansion (Zhang et al., 2009). Although our
data strongly support our conclusion that EGFL7 promotes
PP proliferation, we cannot exclude the possibility that
EGFL7 may also promote foregut epithelium differen-
tiation. In addition, recombinant EGFL7 protein was less
efficient for expansion of PDX1+ progenitors compared
with coculture with endothelial cells. To explain this
discrepancy, we considered two possibilities. First, the re-
combinant EGFL7 proteinmay lack posttranslationalmod-
ifications and might not be as functionally active as native
EGFL7 secreted by endothelial cells. Second, we cannot
exclude the possibility that endothelial cells secrete addi-188 Stem Cell Reports j Vol. 4 j 181–189 j February 10, 2015 j ª2015 The Ational factors that boost the effect of EGFL7. Finally, since
Egfl7 transgene is overexpressed in all endothelia, we
cannot fully rule out the possibility of systemic effects.
The pancreatic development is a highly dynamic process
controlling by multiple pathways. Additional work is
needed to unravel the dynamic interaction of pancreatic
endoderm with endothelial and mesenchymal cell niches.
A complete understanding of the underlying mechanism
may lead to the development of more efficient strategies
to differentiate hESCs/iPSCs into mature glucose-respond-
ing cells in vitro.EXPERIMENTAL PROCEDURES
hESC Culture and Differentiation
HUES8 and H1 cells were routinely cultured on irradiated MEF
feeders in Dulbecco’s modified Eagle’s medium (DMEM)/F12 sup-
plemented with 20% KnockOut Serum Replacement, 2 mM Gluta-
MAX, 1mMnonessential amino acids, 1.1mM b-merceptoethanol,
10 ng/ml basic fibroblast growth factor, and 50 ng/ml normacin. To
differentiate to the PP population, hESCs were cultured on feeders
to 80%–90% confluency and then treated with a series of chemicals
listed in the supplementary method.
Coculture Experiment
MPECs, AKT-HUVECs, and BJ cells were used in the coculture ex-
periments. hESC-derived populations were trypsinized by 0.25%
trypsin (Invitrogen), resuspended in DMEM supplemented with 1
3 B27, and plated at a density of 0.8 3 103 cells/mm2 in 96- or 6-
well plates. MPECs, AKT-HUVECs, or BJ cells were resuspended in
the samemedium and plated down in a ratio of 1:1, 1:3, or 1:10 to
hESC-derived PPs. One day after plating, medium was changed,
and cells were maintained in the incubator for 4 days before fixa-
tion or further analysis. Detailed materials and methods are avail-
able in the Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and two tables and can be found with
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